Research Calls
- Upgrades:
- Amdocs (DOX) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $115
- America Movil SA (AMX) upgraded to Buy from Neutral at New Street; tgt raised to $27
- Expedia Group (EXPE) upgraded to Buy from Hold at Gordon Haskett
- Gilead Sciences (GILD) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt raised to $100
- NovoCure (NVCR) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $104
- Palomar Holdings (PLMR) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $64
- Savara (SVRA) upgraded to Buy from Hold at Jefferies; tgt raised to $4
- Veris Residential (VRE) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $19
- Williams Cos (WMB) upgraded to Buy from Neutral at Citigroup; tgt $36
- Downgrades:
- Commerce Bancshares (CBSH) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $48
- Cullen/Frost (CFR) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $121
- NeoGenomics (NEO) downgraded to Mkt Perform from Outperform at Raymond James
- Prosperity Bancshares (PB) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt raised to $60
- Royal Bank of Canada (RY) downgraded to Neutral from Sector Outperform at CIBC; tgt $4
- Others:
- Ardagh Metal Packaging S.A. (AMBP) initiated with a Hold at Truist; tgt $4
- Carvana (CVNA) resumed with an Equal-Weight at Morgan Stanley; tgt $12
- Coinbase Global (COIN) initiated with a Hold at Berenberg; tgt $55
- First Horizon (FHN) resumed with a Buy at BofA Securities; tgt $14
- GE HealthCare (GEHC) initiated with an Outperform at Oppenheimer; tgt $97
- Rayonier (RYN) initiated with a Hold at Truist; tgt $33
- Vor Biopharma (VOR) initiated with a Buy at Jones Trading; tgt $18
- Western Alliance Bancorp (WAL) resumed with a Buy at BofA Securities; tgt lowered to $42